Our events

In Silico Approaches to Nitrosamine Risk Assessment — 2026 Webinar Series Nitrosamines continue to be one of the most challenging cross-functional issues facing the pharmaceutical industry, touching safety, quality, process development, and regulatory strategy.

Where the world’s leading stability experts present the latest advances in stability science   We are delighted to be co-hosting the annual Science of Stability conference for the third year with FreeThink Technologies as it returns for its 10th year!

Join experts Susan Felter (Vice President at Procter & Gamble), David Ponting (Senior Principal Scientist at Lhasa Limited), and Jessica Halliday (Application Scientist at Lhasa Limited) for an exciting discussion on strengthening informed decision-making using a high-quality carcinogenicity database from Lhasa. 

Nitrosamines remain one of the most complex and evolving challenges in pharmaceutical development, requiring collaboration across toxicology, CMC, and regulatory functions.

We’re excited to return to Brazil for the Lhasa Symposium 2026 – and this year, we’re bringing the conversation to Rio de Janeiro.